Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
Earnings
Dividend
Management Changes
M&A
Analyst
FDA
IPO
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
Enter Symbol
Company
Overview
Research Notes
Company Profile
Competitors
Community
Stock Sentiment
Whisper Estimates
Enter Estimates
Message Board
Analysis
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
35M
Market Cap:
$0.88B
Avg Volume:
833240
P/E Ratio:
-0.010
PEG Ratio:
-0.010
1m
3m
6m
1y
2y
Opinion and Analysis
Stocks Close Higher Amid Earnings; Coach (COH) Tumbles
Jan 23, 2013 04:34 PM |
AAPL
,
AGN
,
AMD
,
COH
,
CREE
,
DGX
Stocks Jump Over 1 Pct On Black Friday; Wal-Mart (WMT) Rises
Nov 23, 2012 01:14 PM |
MAPP
,
MCP
,
RIMM
,
WMT
Futures Rise Amid Greece Optimism; Research In Motion (RIMM) Jumps
Nov 23, 2012 09:17 AM |
MAPP
,
RIMM
,
SHLD
,
TGT
,
WMT
More Articles on MAPP..
Press Releases
Allergan, Inc. Announces Expiration of Tender Offer for All Outstanding Shares of MAP Pharmaceuticals, Inc. and Intent to Exercise Top-Up Option to Effect a Short-Form Merger
Mar 01, 2013 09:00 AM |
AGN
,
MAPP
Free Research Report on Noble Energy, Inc., MAP Pharmaceuticals, Inc., Darden Restaurants, Inc., Canadian National Railway Co. and Sensata Techologies Holdings NV
Feb 19, 2013 09:22 AM |
CNI
,
DRI
,
MAPP
,
NBL
Allergan, Inc. and MAP Pharmaceuticals, Inc. Announce the Federal Trade Commission Has Granted Early Termination of Waiting Period Under Hart-Scott-Rodino Act
Feb 07, 2013 09:00 AM |
AGN
,
MAPP
More Press Releases on MAPP..
SEC Filings
Form 4 MAP Pharmaceuticals, For: Mar 01 Filed by: MCPHERRON MATTHEW V (10K)
Mar 05, 2013 02:18 PM
Form 4 MAP Pharmaceuticals, For: Mar 01 Filed by: CHAI CHRISTOPHER Y (10K)
Mar 04, 2013 08:44 PM
Form 4 MAP Pharmaceuticals, For: Mar 01 Filed by: KELLEY BERNARD J (10K)
Mar 04, 2013 08:37 PM
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
MAPP
Compare to S&P
YTD
59.62 %
49.95 %
4 Weeks
0.61 %
0.27 %
12 Weeks
59.42 %
48.90 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
11.63 %
EPS Growth in Last Year:
-208.57 %
Sales Growth in Last Quarter:
0.00 %
Sales Growth in Last Quarter:
-96.32 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##